Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Columbia Financial Q1 EPS $0.20, Same YoY

Columbia Financial (NASDAQ:CLBK) reported quarterly earnings of $0.20 per share. This is unchanged from the same period last year.

byBenzinga Newsdesk

April 27, 2022

1 minute read

Columbia Financial (NASDAQ:CLBK) reported quarterly earnings of $0.20 per share. This is unchanged from the same period last year.

Raymond James Maintains Strong Buy on Equinix, Raises Price Target to $825

By Benzinga Newsdesk

Today, 2:01 AM

Raymond James analyst Frank Louthan maintains Equinix (NASDAQ:EQIX) with a Strong Buy and raises the price target from $800 to $825.

EQIX

FDA
News

BrainsWay Receives New FDA Clearance For Treating Depression And Anxious Depression

By Benzinga Newsdesk

Today, 2:01 AM

BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it has

BWAY

FDA
News

Marinus Pharma Reports Received FDA Orphan Drug Designation for Ganaxolone In Tuberous Sclerosis Complex Following Topline Phase 2 Open-Label Results

By Benzinga Newsdesk

Today, 2:01 AM

Primary endpoint showed a median 16.6% reduction in 28-day seizure frequency relative to baseline in tuberous sclerosis complex (TSC) patients (n=23) Secondary endpoint of 50% responder rate at 30.4%, consistent with

MRNS

Badger Meter Raises Quarterly Dividend From $0.20/Share To $0.225/Share

By Michael Horton

Today, 2:01 AM

The Board of Directors of Badger Meter, Inc. (NYSE:BMI) today authorized a 12.5% increase in its quarterly common stock dividend to $0.225 per share from $0.20 per share. The increased

BMI

Columbia Financial Q1 EPS $0.20, Same YoY

Related Posts

Raymond James Maintains Strong Buy on Equinix, Raises Price Target to $825

BrainsWay Receives New FDA Clearance For Treating Depression And Anxious Depression

Marinus Pharma Reports Received FDA Orphan Drug Designation for Ganaxolone In Tuberous Sclerosis Complex Following Topline Phase 2 Open-Label Results

Badger Meter Raises Quarterly Dividend From $0.20/Share To $0.225/Share